Ground breaking work by Perou et al. [4] and Sørlie et al. [5] on the molecular classification of breast cancer in to distinct subtypes, luminal, HER2 enriched, and basal-like, confirmed the heterogeneity of this disease. This evidence concerns the gene ERBB2 and breast carcinoma.